First Food and Drug Administration-approved prospective trial of primary intracranial stenting for acute stroke: SARIS (stent-assisted recanalization in acute ischemic stroke).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples